Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate DR vs IR in postmenopausal women
NCT00918749Phase 2Completed
- Sponsor
- Warner Chilcott
- Start
- May 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risedronate in postmenopausal osteoporosis, sponsored by Warner Chilcott. Started May 2009; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00918749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918749.